Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts

Brain transient receptor potential channels and stroke

(2014) Eric Zhang et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Executive Summary: Heart Disease and Stroke Statistics—2013 Update

(2013) Alan S. Go et al.   CIRCULATION

Sulfonylurea Receptor 1 Expression in Human Cerebral Infarcts

(2013) Rupal I. Mehta et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

TRPM4 inhibition promotes angiogenesis after ischemic stroke

(2013) Kok Poh Loh et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Inhibition of the Sur1-Trpm4 Channel Reduces Neuroinflammation and Cognitive Impairment in Subarachnoid Hemorrhage

(2013) Cigdem Tosun et al.   STROKE

An Updated Definition of Stroke for the 21st Century

(2013) Ralph L. Sacco et al.   STROKE

Pilot Study of Intravenous Glyburide in Patients With a Large Ischemic Stroke

(2013) Kevin N. Sheth et al.   STROKE

Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas

(2012) Hagen Kunte et al.   ANNALS OF NEUROLOGY

Time Trends in Systemic Thrombolysis in a Large Hospital-Based Stroke Registry

(2012) O.C. Singer et al.   CEREBROVASCULAR DISEASES

The Sulfonylurea Receptor 1 (Sur1)-Transient Receptor Potential Melastatin 4 (Trpm4) Channel

(2012) Seung Kyoon Woo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sulfonylurea Receptor 1 in Central Nervous System Injury: A Focused Review

(2012) J Marc Simard et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis

(2012) Benjamin Schattling et al.   NATURE MEDICINE

Transient receptor potential melastatin 4 and cell death

(2012) J. Marc Simard et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of Stroke

(2012) J. Marc Simard et al.   Translational Stroke Research

Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-induced endothelial cell death

(2011) Alvaro Becerra et al.   CARDIOVASCULAR RESEARCH

Changes in Stroke Epidemiology, Prevention, and Treatment

(2011) Scott Kinlay   CIRCULATION

Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States

(2011) Opeolu Adeoye et al.   STROKE

The transient receptor potential family of ion channels

(2011) Bernd Nilius et al.   GENOME BIOLOGY

Glibenclamide Reduces Hippocampal Injury and Preserves Rapid Spatial Learning in a Model of Traumatic Brain Injury

(2010) Ashish D. Patel et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Glibenclamide Is Superior to Decompressive Craniectomy in a Rat Model of Malignant Stroke

(2010) J. Marc Simard et al.   STROKE

Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy

(2009) M. Jauss et al.   EUROPEAN JOURNAL OF NEUROLOGY

Molecular mechanisms of microvascular failure in central nervous system injury—synergistic roles of NKCC1 and SUR1/TRPM4

(2009) J. Marc Simard et al.   JOURNAL OF NEUROSURGERY

De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury

(2009) Volodymyr Gerzanich et al.   NATURE MEDICINE

Glibenclamide Reduces Inflammation, Vasogenic Edema, and Caspase-3 Activation after Subarachnoid Hemorrhage

(2008) J Marc Simard et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

National US Estimates of Recombinant Tissue Plasminogen Activator Use

(2008) Dawn Kleindorfer et al.   STROKE

Protective Effect of Delayed Treatment With Low-Dose Glibenclamide in Three Models of Ischemic Stroke

(2008) J. Marc Simard et al.   STROKE